-+ 0.00%
-+ 0.00%
-+ 0.00%

Avadel Pharmaceuticals Q1 EPS $(0.05) Misses $(0.01) Estimate, Sales $52.51M Miss $58.75M Estimate

Benzinga·05/07/2025 11:01:44
Listen to the news
Avadel Pharmaceuticals (NASDAQ:AVDL) reported quarterly losses of $(0.05) per share which missed the analyst consensus estimate of $(0.01) by 400 percent. This is a 83.33 percent increase over losses of $(0.30) per share from the same period last year. The company reported quarterly sales of $52.51 million which missed the analyst consensus estimate of $58.75 million by 10.62 percent. This is a 93.21 percent increase over sales of $27.18 million the same period last year.